Missed Opportunities for HIV Screening in General Practice
Recruiting
Observational Study
HIV Infections
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Other
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The number of new HIV diagnoses in France in 2022 is estimated to be between 4,200 and 5,700. Of these diagnoses, 43% of infections were detected at a late stage. The objective of this study is to identify missed opportunities for HIV testing in general practice and to understand the barriers to testing.
Trial Locations
Loading…
Loading trial locations…
| Facility |
City |
State |
Country |
Status |
Eligibility Criteria
Inclusion Criteria:
* Adult subject (≥18 years)
* diagnosed with HIV infection between January 1, 2021, and July 30, 2024
Exclusion Criteria:
-Subject who arrived in France in the year preceding or during the period between January 1, 2024, and July 30, 2024.
Inclusion Criteria:
* Adult subject (≥18 years)
* diagnosed with HIV infection between January 1, 2021, and July 30, 2024
Exclusion Criteria:
-Subject who arrived in France in the year preceding or during the period between January 1, 2024, and July 30, 2024.